Clinical options in patients with single vessel coronary artery disease and acute myocardial infarction  by Ferlinz, Jack
Editorial Comment 
Clinical Options in Patients With 
Single Vessel Coronary Artery 
Disease and Acute MyQcardia~ 
Infarction* 
JACK FERLINZ, MD, FACC 
cl!icog”. Illin0i.s 
The last few years have brought about many changes in our 
approach to the management of on acute myocardial mhrc- 
lion. A number of investigators have begun to claim that 
certain of their research studies almost mandate a near total 
reorientation of our thinking as to what constitutes the best 
therapy for on acute myocardial ischemic event: the trend is 
rather unmistakably in favor of very aggressive management 
for patients with a fresh heart attack. Nevertbelesr. many 
believe that some of the newer. more aggressive clinical 
optiocs (such as infusion of various thrombolytic ogeots. 
b&mm attgioplasty or even bypass surgery) shoild ty&ally 
be reserved for patients with o life-threatening ischemic 
event. An onco&dicated infarction in patients with known 
or presumed single vessel coronary artery disease is often 
still thought to be best treated conservatively because of its 
usual association with a very low incidence of subsequent 
complications, reinfarction and death. 
Role of conservative versus aggressiw spproarh. In this 
issueoftheloumal, Wilson.3 al. (I)reporton the prognostic 
ramifications for patients with an acute myocardial infarction 
associated with single vessel coronary artery disease. Very 
few didactic data are available for this subset of patients. 
thus the imoortance of this contribution. We alreadv know 
from the lirge cooperative studies such as the E&peon 
Coronary Surgery Study (2) and Coronary Artery Surg :,y 
Study (CA.%) (3) that the long-term prognosis of patients 
with single vessel disease is equally favorable for those 
an acute myocardml mfa:ction. On the one hand. II has been 
<how ML for erample. that even such relatively sophisti- 
cated ooniowsive interventions as exerccisc thallium-201 
myocardiai perfusion scintigraphy are often quite lirmted in 
predaciing no acute ischemic myocardial event in most 
pauenn de\p!te B markedly pocltive wt. It ic therefore quote 
difficult to decide to pursue aggressive tremment too potieot 
wth smgle vessel disease, a “threatened” cr L’coosum- 
mated” recent myocardial infarction and a positive stress 
vintigraphlc wdy. when the relatively low cobcequent 
adverse event mte can be predicted with a fair amount of 
certainty. On the other hand. investigaton conducting other 
noninvasive diagnostic studies. such as exercise echocar- 
diography (51. attemptmg to evaluate the effects of a prior 
hean attack and the extent and loadon of coronary artery 
disease hsve concluded that these tests often accurately 
charactcnrc patients with coronary artery disease, but that 
their sensaivity is best in patients with multivessel involve- 
ment and quite limited in those with single vcwl disease. 
Hence. the key questions are unanswered: what sort of 
noninvasive (or invasive) prognostic evaluation should be 
used in pauents with an acute myocardial infarction due to 
single vessel coronary artery disease. and shooldar when 
should-further aggressive therapy (such as balloon angio- 
pkwy) be carried out’! 
Thus. the argument that single vessel coronary aRery 
disease causing an acute myocardial infarction should most 
often (if not always) be managed conservatively, frequently 
without any iurther diagnostic or therapeutic procedures 
because of the good prognosis, is not entirely convincing 
even though the predictive indications as to which patient 
rhould be treated aggressively are still far from clear. We 
now have some newevidence as to why the myocardium. 
jeopardized by only one of its three coronary vessels, IS 
sometimes seriously injured. A went study (61, for in- 
stance, has shown quite persuasively that the myocardial 
area at ri\k in patients with an acute myocardial infarction is 
governed by variables that can caor: similar sites of occlo- 
sion within a sinale coronary artery to result in a wide range 
random&d to medical or sorgi&+l therapy. Despite these of damage. Fonhermore. this stuby maintains that “many 
convincing data, however. it is not fully (or perhaps not even readdy avadable indexes”-including the coronary artery 
pardotty) warrooted to soggest that these findings alway? anatomy--cannot be used to accurately predict the size of 
accurately represent the prognosis of patients who, in addi- rhe risk area. Tbece investigators appropriately urge o de- 
lion to single vessel coronary artery disease, have also had velopment of quick and accurate approaches to the oswss- 
mem of the size of the mycxardial risk areas. suggestbg that 
sented by the prcscnce of infarct zone thallium redistribution 
in patients with an acute myocardial infarction and sing:e 
vessel coronary disease. Because las already stated) other 
studies 141 using thallium investigations seem to be muck less 
optimistic, one must strongly endorse the authors’ plea for 
future randomized trials targeted to assess the diagnostic and 
therapeutic options in patients with an acute ischemic event 
and sinele vessel disease. Such a broader effort is needed not 
only be&se of the continuing divergent herapeutic recom- 
mendations (often including a substantial proponion of Pa- 
tients with single VCSSCI disease) (7). but also because certain 
problems in the present study may hinder interpretation of 
its conctusions. It is troublesome lhat no attcmot was made 
in this study to standardize the medical therapy. For exam- 
“le. it is a relatively common practice today to treat patients 
with Q wave myocardial infarciion with a beta-adrenergic 
blocker. those with a non-Q wave infarction with diltiazem 
or those with unstable angina wi!h aspirin because a number 
of studies show that such interventions can improve prog- 
nosis. The results of this reoort could therefore be a bit 
skewed because the commo~iy considered “best therapy” 
might not have been uniformly followed and different med- 
ics approaches may have kah a substantial impact on the 
eventual clinical outcome. Furthermore, a number of 
hypotheses evoked in this study are related to myocardial 
oxygen supply and demand. [t would have been extremely 
useful to see if the analysis of left ventricular wali mass 
would further classify its subjects according to future coro- 
nary events. This is even more important now that we are 
beginning to recognize that increases in left ventricular mass 
(in patients who presumably have no coronary artery dis- 
ease) predispose to significant subsequent cardiovascular 
morbid events (8). Unfortunately, contrast left vetttrictdog- 
rapky was not performed in this study, and these rather 
important ventricular wall mass date are therefore appar- 
ently unavailable. 
Despite these difficulties, however. the work by Wilson et 
rd. (I) represents a much needed first step toward a better 
understanding of which diagnostic evaluations give the best 
overview of problems confronting a patient with an acme 
myocardial infarction and Crgle vessel coronary artery 
disease. It should form P solid basis for the next crucial step: 
how to use these and subsequent diagnostic data to decide 
which of these patients should be treated aggressively with 
angioplasty or surgery and which can be safely managed 
with a conservative approach. 
